Free Trial
NASDAQ:CRON

Cronos Group (CRON) Stock Price, News & Analysis

Cronos Group logo
$2.55 -0.03 (-1.16%)
Closing price 04:00 PM Eastern
Extended Trading
$2.54 -0.01 (-0.39%)
As of 06:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cronos Group Stock (NASDAQ:CRON)

Advanced

Key Stats

Today's Range
$2.54
$2.61
50-Day Range
$1.95
$2.97
52-Week Range
$1.60
$3.16
Volume
1.68 million shs
Average Volume
2.03 million shs
Market Capitalization
$976.37 million
P/E Ratio
51.00
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Cronos Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
36th Percentile Overall Score

CRON MarketRank™: 

Cronos Group scored higher than 36% of companies evaluated by MarketBeat, and ranked 767th out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Cronos Group are expected to grow in the coming year, from ($0.03) to $0.03 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cronos Group is 51.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 234.45.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cronos Group is 51.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.66.

  • Price to Book Value per Share Ratio

    Cronos Group has a P/B Ratio of 0.88. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cronos Group's valuation and earnings.
  • Percentage of Shares Shorted

    1.48% of the float of Cronos Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Cronos Group has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cronos Group has recently increased by 12.31%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cronos Group does not currently pay a dividend.

  • Dividend Growth

    Cronos Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.48% of the float of Cronos Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Cronos Group has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cronos Group has recently increased by 12.31%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Cronos Group has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Cronos Group this week, compared to 2 articles on an average week.
  • Search Interest

    11 people have searched for CRON on MarketBeat in the last 30 days. This is an increase of 22% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cronos Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.90% of the stock of Cronos Group is held by insiders.

  • Percentage Held by Institutions

    Only 8.71% of the stock of Cronos Group is held by institutions.

  • Read more about Cronos Group's insider trading history.
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRON Stock News Headlines

Arizona-made nanochips the new millionaire maker?
George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves.tc pixel
Crypto.com's CRO token wipes out over $6 billion
See More Headlines

CRON Stock Analysis - Frequently Asked Questions

Cronos Group's stock was trading at $2.02 at the beginning of 2025. Since then, CRON shares have increased by 26.2% and is now trading at $2.55.

Cronos Group Inc. (NASDAQ:CRON) posted its quarterly earnings results on Thursday, August, 7th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.08. The company earned $33.46 million during the quarter, compared to the consensus estimate of $45.73 million. Cronos Group had a net margin of 14.19% and a negative trailing twelve-month return on equity of 3.78%.
Read the conference call transcript
.

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
8/07/2025
Today
10/06/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CRON
CIK
1656472
Fax
N/A
Employees
450
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
$0.05
Trailing P/E Ratio
51.10
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$41.08 million
Net Margins
14.19%
Pretax Margin
14.45%
Return on Equity
-3.78%
Return on Assets
-3.62%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
24.65
Quick Ratio
23.53

Sales & Book Value

Annual Sales
$117.61 million
Price / Sales
8.32
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.90 per share
Price / Book
0.88

Miscellaneous

Outstanding Shares
382,890,000
Free Float
356,473,000
Market Cap
$978.28 million
Optionable
Optionable
Beta
1.12

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:CRON) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners